Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

1 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14,558 shares of 43,411,663 outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include Slate Path Capital LP (2,402,455 shares), BlackRock Inc. (2,338,765 shares), VANGUARD GROUP INC (2,132,905 shares), Bleichroeder LP (1,755,028 shares), GEODE CAPITAL MANAGEMENT, LLC (813,285 shares), STATE STREET CORP (683,695 shares), Robertson Stephens Wealth Management, LLC (478,500 shares), DIMENSIONAL FUND ADVISORS LP (457,985 shares), NORTHERN TRUST CORP (381,367 shares), and Monaco Asset Management SAM (342,242 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.